Publications by authors named "Helen Millns"

Claim this Profile
E
Efficacy and activity of gepotidacin against bacterial uropathogens, including drug-resistant phenotypes, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3).
Nicole E Scangarella-Oman, Deborah L Butler, John Breton, Derrek Brown, Cara Kasapidis, Helen Millns

Antimicrob Agents Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plain language summary: efficacy and safety of gepotidacin, a new oral antibiotic, compared with nitrofurantoin, a commonly used oral antibiotic, for treating uncomplicated urinary tract infection.
Florian Wagenlehner, Caroline R Perry, Thomas M Hooton, Nicole E Scangarella-Oman, Helen Millns

Future Microbiol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials.
Florian Wagenlehner, Caroline R Perry, Thomas M Hooton, Nicole E Scangarella-Oman, Helen Millns

Lancet· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Gepotidacin as Treatment of Uncomplicated Urogenital Gonorrhea (EAGLE-1): Design of a Randomized, Comparator-Controlled, Phase 3 Study.
Caroline R Perry, Nicole E Scangarella-Oman, Helen Millns, William Flight, Sally Gatsi

Infect Dis Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial.
Divya Mohan, Harry Rossiter, Henrik Watz, Charles Fogarty, Rachael A Evans, Helen Millns

Thorax· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study.
Duncan Richards, Helen Millns, Louise Cookson, Mary Ann Lukas

Orphanet J Rare Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study.
Ashutosh Wechalekar, Gunnar Antoni, Wasfi Al Azzam, Mats Bergström, Swethajit Biswas, Helen Millns

BMC Cardiovasc Disord· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies.
Emiliangelo Ratti, Paolo Bettica, Robert Alexander, Graeme Archer, David Carpenter, Helen Millns

J Psychopharmacol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis